Melatonin: What the Evidence Does and Doesn’t Show

By Anas, Editor at HealthForge · Published 27 August 2026 · 18 min read

Pooled data from randomized trials show that melatonin helps most people fall asleep about seven minutes faster than placebo.¹ The effect is real, and it is also small — a useful place to start with a supplement that is often talked about as if it were a sedative.

Melatonin is a hormone, not a sleeping pill. Its clearest job in the body is signaling time, not forcing sleep, and that single distinction explains most of what follows: where the evidence is strong, where it is thin, and where popular claims run ahead of the data.

This guide keeps three questions separate that tend to get blended together — what melatonin reliably does, what it might do, and what it does not do. The aim is realistic expectations, drawn from the trials themselves.

In this article

1. The short version
2. What melatonin is and how it works
3. What the evidence supports
4. Where the evidence is weak or mixed
5. Melatonin for insomnia: what improves and what does not
6. Melatonin for jet lag and circadian rhythm disorders
7. What we know about long-term safety
8. Side effects, interactions, and who should avoid it
9. How to think about dose, timing, and product quality
10. Special populations: children and older adults
11. What this means if you’re considering it
12. What we still don’t know
13. Common questions
14. Where this leaves us
15. Related reading

What melatonin is and how it works

Melatonin is produced in the pineal gland and released almost entirely at night. Darkness switches on its synthesis through the enzyme AANAT, under the control of the brain’s master clock, the suprachiasmatic nucleus.³³ Rising melatonin is, in effect, the body’s internal announcement that biological night has begun. (For the broader picture of how morning light and timing set your body clock, the same master clock sits at the center of the story.)

It works through two receptors, MT1 and MT2, both G protein-coupled receptors that carry this circadian message to tissues throughout the body.³⁴ In humans they mainly couple to Gi/o proteins and lower cyclic AMP — one of the mechanisms by which melatonin nudges the clock and gently promotes sleepiness.³⁵

The practical lesson from this biology is straightforward. Melatonin is a timing cue. A well-timed small dose can shift the clock; a poorly timed one can do little, or even push it the wrong way. That is why “when” keeps coming up in the evidence below.

What the evidence supports

Three uses hold up reasonably well.

Falling asleep faster. A 2013 meta-analysis in PLOS ONE found melatonin cut sleep onset latency by about seven minutes versus placebo across primary sleep disorders, with smaller effects on total sleep time and sleep quality.¹ A 2024 dose-response meta-analysis in the Journal of Pineal Research found this benefit builds with dose up to roughly 4 mg per day, after which more offers no added advantage.² (To weigh these pooled results critically, it helps to understand how meta-analyses fit into the evidence hierarchy.)

Jet lag. A Cochrane review concluded that melatonin taken close to bedtime at the destination reduces jet lag on journeys crossing five or more time zones, with the caveat that the trials were small and varied.⁸ A later systematic review reached the same practical conclusion: oral melatonin probably reduces jet lag symptoms.¹⁰

Shifting circadian phase. Controlled human studies show melatonin can move the internal clock earlier or later depending on when it is taken.³² This is the mechanism behind its use in delayed sleep phase and jet lag, and it is where the physiology and the clinical evidence line up most cleanly.

On sleep quality specifically, a 2021 meta-analysis found melatonin improved subjective quality on the Pittsburgh Sleep Quality Index in adults⁷ — a genuine finding, though one based on questionnaires rather than objective sleep recordings.

Where the evidence is weak or mixed

The picture changes once melatonin is asked to do more than start sleep.

Its effect on total sleep time is small, and its effect on staying asleep through the night is inconsistent. A network meta-analysis found melatonin improved sleep onset latency more reliably on objective measures than on people’s own reports, and that its benefit for broader insomnia outcomes was limited.⁵ Staying asleep depends on cycling smoothly through the four stages of sleep — something a timing cue is not well designed to control.

For chronic insomnia in adults, the evidence is genuinely disappointing. A 2022 systematic review in Sleep Medicine Reviews found no significant benefit for sleep onset latency, total sleep time, or sleep efficiency in adults, while children and adolescents fared better.⁴ The population most likely to reach for melatonin — adults with ongoing insomnia — is the group in which it performs least convincingly. For them, approaches such as CBT-I and chronic insomnia treatment carry far stronger evidence.

This is the core misunderstanding worth correcting. Melatonin is not a broad remedy for poor sleep. It is a targeted tool for problems of sleep timing and sleep onset.

Melatonin for insomnia: what improves and what does not

When melatonin helps with insomnia, it usually helps you fall asleep sooner. What it does not reliably do is increase how long you sleep or how refreshed you feel.

The size of the effect depends on what you measure. Objective recordings tend to show a clearer benefit for sleep onset than sleep diaries do,⁵ and the effect is larger in delayed sleep phase syndrome than in ordinary insomnia — a 2005 meta-analysis found the difference substantial.⁶

There are exceptions. A randomized trial in middle-aged patients with insomnia found that four weeks of melatonin improved several objective measures, including total sleep time.³⁷ But this is a single study, set against a much larger body of adult evidence showing modest or absent effects. Treat it as a hint, not a headline.

Melatonin for jet lag and circadian rhythm disorders

This is melatonin’s strongest use case, and the reason is mechanistic: jet lag is a timing problem, and melatonin is a timing signal.

The pattern across the trials is consistent. A dose taken near bedtime at your destination helps most when you cross at least five time zones,⁸ and the effect is generally clearer for eastward travel, which requires advancing the clock. One randomized controlled trial found 5 mg reduced jet lag severity after eastbound flights.⁹

Timing here is not a detail; it is the mechanism. Human phase-response studies show maximal advances of the clock when about 0.5 mg is taken a few hours before the natural evening rise in melatonin,¹² and similar timing-dependent shifts with 3 mg.¹³ Take the same dose at the wrong time and it can do nothing.

Shift work

The evidence is thinner and more short-term. A systematic review in Nutrients found melatonin improved some outcomes in shift workers, including daytime sleepiness and sleep onset latency, but the studies were mostly brief and of limited quality.¹¹ It may help some shift workers sleep during the day; the case is far weaker than for jet lag.

What we know about long-term safety

Most of what we can say with confidence concerns short-term use. A 2020 systematic review found melatonin’s adverse events were few and generally mild to moderate, with no life-threatening or major clinically significant events.¹⁹ A separate meta-analysis found that higher doses did not raise serious adverse events, though they did increase non-serious ones such as drowsiness, headache, and dizziness.²⁰

For genuinely long-term use, the honest answer is that we know less than we would like. A review of studies lasting at least six months found adverse events uncommon and usually minor,³⁰ and a review of chronic use concluded that low-to-moderate doses — roughly 5–6 mg per day or less — appear generally safe, while explicitly noting that long-term evidence remains limited.²⁹ A placebo-controlled trial of chronic 10 mg dosing found no toxicological effect over the study period.³¹

Read together, these studies point to a fair summary: no red flags, but not enough long-duration randomized data to call years of nightly use definitively safe. Reassuring is not the same as proven.

Side effects, interactions, and who should avoid it

The commonly reported side effects are mild — daytime sleepiness, fatigue, dizziness, headaches, and gastrointestinal upset, with occasional reports of worsened seizures or asthma in susceptible people.³⁶

Interactions deserve more attention than they usually get. Melatonin is broken down mainly by the liver enzyme CYP1A2, so anything that changes that enzyme’s activity changes melatonin levels.²⁴ Oral contraceptives, for instance, raise melatonin exposure roughly four- to fivefold by slowing this metabolism.²⁴ The potent CYP1A2 inhibitor 5-methoxypsoralen can meaningfully impair melatonin clearance.²³ Anyone on drugs that affect CYP1A2 — or already taking sedatives — has reason to be cautious.

Two groups should generally avoid it without medical guidance. Reviewers advise against use during pregnancy and breastfeeding because human data are insufficient.²¹ And because supplement quality is so variable (more on that below), anyone who is medically vulnerable should be especially careful about what they are actually swallowing.

How to think about dose, timing, and product quality

More is not better. The dose-response evidence points to benefit plateauing around 4 mg per day for sleep onset,² with higher doses adding side effects rather than sleep.²⁰ For circadian shifting, effective doses can be much smaller — often 0.5 mg — with timing doing the real work.¹²

Formulation changes the pharmacokinetics. Immediate-release melatonin has nearly twice the bioavailability of prolonged-release versions,¹⁴ while extended-release formulations produce a lower peak, a later peak, and more sustained overnight levels.¹⁵ Even so, oral melatonin’s absolute bioavailability is only about 2.5–3%, meaning most of a swallowed dose never reaches the bloodstream intact.¹⁶

The most underappreciated issue is what is in the bottle. One analysis found melatonin content ranging from 83% below to 478% above the label claim, with substantial lot-to-lot variation.¹⁷ A 2025 JAMA survey of US products found content spanning 0% to 667% of the declared dose.¹⁸ That variability undermines any precise dosing advice and is a strong argument for third-party-tested products.

For readers who want the underlying science rather than a supplement, Matthew Walker’s Why We Sleep is a readable overview of sleep and circadian biology, best read alongside the primary evidence rather than as a substitute for it.

Special populations: children and older adults

These two groups matter because the adult evidence does not transfer cleanly to either.

Children and adolescents. Melatonin tends to work better here than in adults. In idiopathic chronic insomnia, a 2023 meta-analysis found it reduced sleep latency by about 18 minutes, though overall certainty was low.²⁵ In children with neurodevelopmental disorders such as autism, a meta-analysis of 34 randomized trials found improvements in both sleep onset latency and total sleep time, with tolerability similar to placebo.²⁶ On safety, reviews find no increase in serious adverse events but more non-serious ones, and long-term data are limited.²² Pediatric use is best supervised by a clinician, not self-directed.

Older adults. People over 55 show a more favorable response, particularly to prolonged-release formulations. Trials found improvements in sleep quality, sleep onset, and morning alertness when melatonin was taken one to two hours before bed,²⁷ and a six-month randomized trial reported improved sleep latency in elderly patients regardless of their own melatonin levels.²⁸ This is one of the clearer adult use cases.

What this means if you’re considering it

Melatonin is most worth trying when the problem is one of timing or difficulty falling asleep — jet lag after a long eastward flight, a delayed sleep phase, or trouble initiating sleep — rather than frequent night waking or unrefreshing sleep. When the real issue is fragmented sleep, foundational evidence-based sleep hygiene will usually do more than a supplement.

If you do try it, the evidence favors a low dose — many circadian uses rely on 0.5–3 mg, and sleep-onset benefit plateaus near 4 mg — taken at a consistent, deliberately chosen time rather than simply at lights-out. For jet lag, that means bedtime at your destination.⁸ For shifting your clock earlier, it means the early evening, before your natural melatonin rise.¹²

Because label accuracy is a real problem,¹⁸ a product with independent third-party testing is one of the few quality signals worth acting on. And if you take prescription medications — especially sedatives, oral contraceptives, or anything metabolized through CYP1A2 — raise melatonin with a pharmacist or clinician first.²⁴ None of this is medical advice; it is context for a more informed conversation.

What we still don’t know

The evidence has clear boundaries. Long-term safety across years of nightly use is not established; the reassuring data mostly come from studies of six months or less.³⁰ Puberty-related and other endocrine questions in children remain open.

Effect sizes are also easy to overstate. Statistically significant is not the same as clinically meaningful, and several reviews openly question whether a seven-minute head start on sleep changes how people actually feel.¹ Much of the sleep-quality evidence rests on questionnaires rather than objective recordings.⁷

And supplement variability contaminates the entire literature. When a product may contain a fraction or several times its labeled dose,¹⁸ both efficacy and safety findings carry an asterisk. The science describes melatonin the molecule more reliably than it describes the tablet in your hand.

Common questions

Does melatonin actually work for insomnia?

For adults with chronic insomnia, the benefit is weak or unclear; a 2022 systematic review found no significant effect on sleep onset, total sleep time, or efficiency in adults.⁴ It works better for falling asleep than for staying asleep, and better in children, adolescents, and adults over 55 than in the general adult population.

How much melatonin should I take, and when?

Sleep-onset benefit appears to plateau around 4 mg per day, with no added advantage above that.² For shifting your body clock, much smaller doses — around 0.5 mg — taken hours before your natural evening melatonin rise can be more effective than a larger dose at bedtime.¹² Timing often matters more than amount.

Is melatonin safe to take long term?

Short-term use looks safe, with mostly mild side effects.¹⁹ Studies lasting six months or more report uncommon, minor adverse events,³⁰ but truly long-term randomized data are lacking, so years of nightly use cannot be called definitively proven safe.²⁹

Does melatonin help with jet lag?

This is one of its best-supported uses. A Cochrane review found melatonin taken at destination bedtime reduces jet lag when crossing five or more time zones,⁸ with the effect generally clearer for eastward travel.⁹

Can children take melatonin?

It tends to work better in children than adults, especially for sleep onset and in neurodevelopmental conditions,²⁶ and reviews find no increase in serious adverse events.²² Still, long-term pediatric data are limited, so use is best guided by a clinician rather than self-directed.

Where this leaves us

Melatonin is a genuinely useful tool that has been asked to do too much. It shortens the time to fall asleep by a modest margin, and it earns its keep for circadian problems — jet lag, delayed sleep phase, and clock-shifting — where its role as a timing signal matches the job.⁸³²

What it is not is a general fix for poor or fragmented sleep, particularly in the adults most likely to buy it.⁴ Used at a low dose, at a deliberate time, with a reputable product, it is a reasonable thing to try for the right problem. Expecting it to rebuild a full night’s sleep is where realistic expectations part ways with the evidence.

Related reading

• Circadian rhythm 101: how morning light and timing set your body clock
• CBT-I and chronic insomnia treatment
• Evidence-based sleep hygiene
• The four stages of sleep
• How meta-analyses fit into the evidence hierarchy

Sources

1. PLOS ONE, 2013: Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders
2. Journal of Pineal Research, 2024: Optimizing the Time and Dose of Melatonin as a Sleep-Promoting Drug: A Dose-Response Meta-Analysis
3. Journal of Sleep Research, 2023: Efficacy of melatonin and ramelteon for the acute and long-term management of insomnia disorder in adults
4. Sleep Medicine Reviews, 2022: Efficacy of melatonin for chronic insomnia: Systematic review and meta-analysis
5. Sleep Medicine Reviews, 2020: A Systematic Review and Network Meta-Analysis of the Efficacy of Exogenous Melatonin in Insomnia
6. Sleep Medicine Reviews, 2005: The Efficacy and Safety of Exogenous Melatonin for Primary Sleep Disorders: A Meta-Analysis
7. Sleep Medicine Reviews, 2021: Effect of melatonin supplementation on sleep quality: a systematic review and meta-analysis
8. Cochrane Database of Systematic Reviews, 2002: Melatonin for the Prevention and Treatment of Jet Lag
9. Journal of Travel Medicine, 2001: Effectiveness and Tolerability of Melatonin and Zolpidem for the Alleviation of Jet Lag
10. Journal of Travel Medicine, 2016: Is Melatonin Useful for Jet Lag?
11. Nutrients, 2022: The Effects of Exogenous Melatonin on Shift Work Sleep Disorder and Sleep Quality: A Systematic Review and Meta-Analysis
12. Journal of Clinical Endocrinology & Metabolism, 2010: Human Phase Response Curves to Three Days of Daily Melatonin
13. Journal of Clinical Endocrinology & Metabolism, 2007: A three pulse phase response curve to three milligrams of melatonin in humans
14. Pharmaceutics, 2023: Bioavailability of Melatonin after Administration of an Oral Prolonged-Release Formulation Compared to an Immediate-Release Formulation
15. Journal of Clinical Sleep Medicine, 2023: A Randomized, Double-Blind, Crossover Study to Assess the Pharmacokinetics of Extended-Release Melatonin Compared to Immediate-Release Melatonin
16. Journal of Pineal Research, 2016: Pharmacokinetics of oral and intravenous melatonin in healthy volunteers
17. Journal of Clinical Sleep Medicine, 2017: Melatonin Natural Health Products and Supplements
18. JAMA, 2025: A Survey of Melatonin in Dietary Supplement Products Sold in the United States
19. Sleep Medicine Reviews, 2020: Adverse Events Associated with Melatonin for the Treatment of Primary or Secondary Sleep Disorders
20. Journal of Pineal Research, 2022: Safety of higher doses of melatonin in adults: A systematic review and meta-analysis
21. BioMed Research International, 2015: The Safety of Melatonin in Humans
22. European Journal of Pediatrics, 2023: The short-term and long-term adverse effects of melatonin treatment in children and adolescents
23. Clinical and Experimental Pharmacology and Physiology, 2014: Potential drug interactions with melatonin
24. Clinical Pharmacokinetics, 2008: Clinical pharmacokinetics of melatonin: A systematic review
25. eClinicalMedicine, 2023: Use of melatonin in children and adolescents with idiopathic chronic insomnia: a systematic review, meta-analysis, and clinical recommendation
26. Sleep Medicine Reviews, 2022: Efficacy on sleep parameters and tolerability of melatonin in children and adolescents with neurodevelopmental disorders
27. Current Medical Research and Opinion, 2007: Efficacy of prolonged release melatonin in insomnia patients aged 55 years and over
28. BMC Medicine, 2010: Nightly treatment of primary insomnia with prolonged release melatonin for 6 months
29. Frontiers in Endocrinology, 2023: Chronic Administration of Melatonin: Physiological and Clinical Considerations
30. Sleep Medicine Reviews, 2023: Adverse events in long-term studies of exogenous melatonin
31. Journal of Pineal Research, 2000: Randomized, double-blind clinical trial of the toxicology of chronic melatonin treatment
32. Journal of Clinical Endocrinology & Metabolism, 1995: Melatonin marks circadian phase position and resets the endogenous circadian pacemaker in humans
33. Endotext, 2022: Physiology of the Pineal Gland and Melatonin
34. Pharmacological Reviews, 2010: Nomenclature, Classification, and Pharmacology of G Protein-Coupled Melatonin Receptors
35. Nature Communications, 2022: Structural basis of the ligand binding and signaling mechanism of melatonin receptors
36. BMC Medicine, 2018: Melatonin and health: an umbrella review of health outcomes and adverse effects
37. Journal of Sleep Research, 2020: Efficacy of melatonin for sleep disturbance in middle-aged primary insomnia: a randomized placebo-controlled trial
38. NCBI Bookshelf, 2021: Light at Night and Night Shift Work: Circadian Disruption Studies